Identifying real differences in live birth rates between HMG and rFSH in IVF. (Q37465370)

20 August 2017

1 reference

title

Identifying real differences in live birth rates between HMG and rFSH in IVF. (English)

1 reference

20 August 2017

Masoud Afnan

1

1 reference

20 August 2017

1 January 2009

1 reference

Reproductive BioMedicine Online

20 August 2017

1 reference

20 August 2017

18 Suppl 2

1 reference

20 August 2017

25-30

1 reference

Efficacy and safety of human menopausal gonadotrophins versus recombinant FSH: a meta-analysis

20 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

FSH isoform composition of commercial gonadotrophin preparations: a neglected aspect?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

Ovarian responses to recombinant FSH or HMG in normogonadotrophic women following pituitary desensitization by a depot GnRH agonist for assisted reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

The number needed to treat: a clinically useful measure of treatment effect

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

The distribution of FSH receptor isoforms is related to basal FSH levels in subfertile women with normal menstrual cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

What is the most relevant standard of success in assisted reproduction?: no single outcome measure is satisfactory when evaluating success in assisted reproduction; both twin births and singleton births should be counted as successes

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

Meta-Analysis. Potentials and promise

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

The effect of preincubation period of oocytes on nuclear maturity, fertilization rate, embryo quality, and pregnancy outcome in IVF and ICSI

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

Impact of oocyte pre-incubation time on fertilization, embryo quality and pregnancy rate after intracytoplasmic sperm injection.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

High rates of embryo wastage with use of assisted reproductive technology: a look at the trends between 1995 and 2001 in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

Follitropin receptors contain cryptic ligand binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

Significance of cumulus oophorus in in-vitro fertilization and oocyte viability and fertility.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

High rate of biological loss in assisted reproduction: it is in the seed, not in the soil.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

Ovarian Response to Follicle-Stimulating Hormone (FSH) Stimulation Depends on the FSH Receptor Genotype

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

Highly purified HMG versus recombinant FSH for ovarian stimulation in IVF cycles.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

Exogenous luteinizing hormone activity may influence the treatment outcome in in vitro fertilization but not in intracytoplasmic sperm injection cycles.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

The effect of HMG and recombinant human FSH on oocyte quality: a randomized single-blind clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

Preincubation of human oocytes may improve fertilization and embryo quality after intracytoplasmic sperm injection.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

Batch-to-batch consistency of human-derived gonadotrophin preparations compared with recombinant preparations

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960445-2

7 January 2021

Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003973

Identifiers

DOI

10.1016/S1472-6483(10)60445-2

1 reference

20 August 2017

1 reference

PubMed ID

19406028